Gear Up for Sabra (SBRA) Q4 Earnings: Wall Street Estimates for Key Metrics

Group 1 - Wall Street analysts expect Sabra Healthcare (SBRA) to report quarterly earnings of $0.36 per share, reflecting a year-over-year increase of 9.1% [1] - Revenues are anticipated to reach$ 183.22 million, which represents a 12.1% increase from the same quarter last year [1] - The consensus EPS estimate has been revised 1.9% higher over the last 30 days, indicating a collective reevaluation by analysts [1][2] Group 2 - Analysts predict 'Revenues- Interest and other income' will be $9.71 million, showing a change of +6.7% from the previous year [4] - 'Revenues- Resident fees and services' are expected to reach$ 75.05 million, indicating a year-over-year change of +22.5% [4] - 'Revenues- Rental and related revenues' are projected to be $96.34 million, reflecting a change of +3.5% from the prior-year quarter [4] Group 3 - 'Depreciation and amortization' is estimated to be$ 43.11 million, slightly up from $42.88 million a year ago [5] - Over the past month, shares of Sabra have returned -2.5%, contrasting with the Zacks S&P 500 composite's +4.7% change [5] - SBRA currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [5]